The EIBIR two years on
'There is no proof that some new procedures are better than the conventional ones or than clinical examination'
Therapy
First prostate cancer biomarker identified in urine
A potential biomarker for cancer has been identified in urine.
Prostate Cancer Screening
To date, there is insufficient knowledge as to the cause of this disease, or how to prevent it. We asked some of our EH correspondents to report on measures taken in their countries to ensure that men are made more aware of this disease and whether screening services are provided for early prostate cancer detection.
MANAGEMENT
Accreditation and standards of Excellence in Europe
Article • Benign tumours
Uterine fibroids: studies indicate high success rate for radiological treatment
Uterine fibroids are the most common benign tumours in women. Treatment is only necessary if the fibroids cause pain and bleeding due to their size and position. Minimally-invasive fibroid embolisation is a gentle, efficient and long-lasting treatment for their removal, leaving the uterus intact. The first evaluations of several international long-term studies have indicated a high success rate…
Prostate Cancer Screening
To date, there is insufficient knowledge as to the cause of this disease, or how to prevent it. We asked some of our EH correspondents to report on measures taken in their countries to ensure that men are made more aware of this disease and whether screening services are provided for early prostate cancer detection.
The European Cancer Therapy Market
Cancer may well surpass cardiovascular diseases as the primary case of death in Europe by 2012. To prevent this from happening, cancer therapeutics have to shift in focus from the treatment of symptoms to offering a total cure, despite the complex, multifactorial nature of cancer indications.
Nanotechnology to accelerate bone growth
In recent years, stem cells have become a hot topic of investigation with studies suggesting revolutionary medical benefits due to their ability to be converted into selected types of newly generated cells. Scientists have now come up with a way to help accelerate bone growth through the use of nanotubes and stem cells. This could lead to quicker and better recovery, for example after orthopedic…
New Faster Cancer Treatment Procedure Completed in One Day
HDR brachytherapy patients require at least six hours between treatment sessions to enable the body to recover. A leading provincial cancer hospital has become the first in the UK - and one of the first in Europe - to deliver two high dose rate (HDR) brachytherapy radiotherapy treatments in the same day.
TIARA enhances therapists' workflow
A new IT system, designed to improve the efficiency and effectiveness of the therapy department at the Royal Orthopaedic Hospital (ROH) NHS Foundation Trust in Birmingham, is reported to have shown clear benefits for therapists, managers and patients.
US oncology expertise to spread globally
The University of Pittsburgh Medical Center and GE Healthcare plan to establish over 25 local cancer centres in various countries within the coming decade.
Healthcare sector to fight ATB over-consumption
Czech hospitals are seeking powerful inspiration regarding antibiotics (ATB) consumption from France, where a recent public campaign helped to decrease ATB consumption by 30%.
Luhacovice
Admittedly not one of the easiest names to pronounce but a name to note: Luhacovice in the Czech Republic.
New device brings clarity to critical limb ischaemia
About 4 million people in Germany suffer from bad or non healing wounds. Most important for a good wound healing is a good sufficient supply with oxygen.
Plasma vaporisation
Benign prostatic hyperplasia (BPH) is the most common cause of voiding disorders in men. The hyperplastic tissue constricts the urethra and leads to lower urinary tract symptoms (LUTS) that can be differentiated into irritative and obstructive symptoms. These can quite dramatically impact on the quality of life of affected people.
EPPENDORF and MEDICA
When the first `diagnostics week´ was held 40 years ago the exhibition attracted just a handful of companies, all from the laboratory sector. At the time, no one could have known that this sedate event would eventually develop into the world's biggest medical exhibition, MEDICA.
The first cross-border European University Hospital
During the MCC Hospital World 2008 congress, held in Berlin this September, speakers from international firms and hospital chains discussed the demands and necessities for future healthcare.
Lumpectomy is not advised if breast cancer returns
A mastectomy is prudent when breast cancer returns after a lumpectomy, because survival rates are higher for those who have another lumpectomy, according to a new study published in the American Journal of Surgery in October.
Revisions to the diabetes treatment algorithm
A panel of experts, convened by the American Diabetes Association and the European Association for the Study of Diabetes, has issued updated treatment recommendations for type 2 diabetes, in a consensus statement published online in two journals: Diabetes Care and Diabetologia*.
Philips and Neuronexus to research next generation deep brain stimulation device
NeuroNexus Technologies and Philips Research announced that they have signed a joint research agreement to develop next-generation deep brain stimulation devices with the ambition to improve the treatment of neurological diseases and psychiatric disorders.
Diabetic foot
The 2nd international symposium `Diabetic foot: surgery, therapy, rehabilitation´ took place on the beginning of October in St. Petersburg. Olga Ostrovskaya reports from Russia
MEDICA 2008 opens its doors
When from 19 to 22 November the world's largest medical fair takes place in Dusseldorf, the entire city is in a kind of emergency state: hotels are bustin' out of their seams, traffic periodically comes to a standstill and at night exhibitors and visitors alike crowd the narrow streets of the Altstadt and the fancy hotel bars and enjoy whatever entertainment North Rhine-Westphalia's capital has…
Breast cancer
Olwen Glynn Owen reports on MammaPrint, a test that pinpoints the risk of breast cancer recurrence from the primary tumour's genetic make-up. Women with breast cancer tumours under
Infusion technology from Fresenius Kabi
Infusion technology has come a long way in the past decade, explains Stéphane Ruton, Director of Strategic Marketing for IV Technology at Fresenius Kabi, which focuses on infusion therapies and clinical nutrition, as well as the respective medical devices.
Erster Europäischer Kongress für Integrative Medizin (ECIM)
Als Kongresspräsident lud Professor Stefan N. Willich von der Berliner Charité zur Diskussion über die Möglichkeit, dem Wunsch der Patienten nach integrierter medizinischer Versorgung nachzukommen. Denn bei chronischen oder Herz-Kreislauf-Erkrankungen zum Beispiel möchten die Menschen sowohl schulmedizinische Aufklärung und Behandlung durch ihren Arzt als auch…
